Rein Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNTX and other ETFs, options, and stocks.About RNTX
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
CEOBrian J. Windsor
CEOBrian J. Windsor
Employees11
Employees11
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2001
Founded2001
Employees11
Employees11
RNTX Key Statistics
Market cap35.62M
Market cap35.62M
Price-Earnings ratio-0.52
Price-Earnings ratio-0.52
Dividend yield—
Dividend yield—
Average volume188.28K
Average volume188.28K
High today$1.38
High today$1.38
Low today$1.35
Low today$1.35
Open price$1.37
Open price$1.37
Volume163.23K
Volume163.23K
52 Week high$3.50
52 Week high$3.50
52 Week low$1.04
52 Week low$1.04
Stock Snapshot
With a market cap of 35.62M, Rein Therapeutics(RNTX) trades at $1.35. The stock has a price-to-earnings ratio of -0.52.
As of 2025-12-06, Rein Therapeutics(RNTX) stock has fluctuated between $1.35 and $1.38. The current price stands at $1.35, placing the stock 0.0% above today's low and -2.2% off the high.
Rein Therapeutics(RNTX) shares are trading with a volume of 163.23K, against a daily average of 188.28K.
During the past year, Rein Therapeutics(RNTX) stock moved between $1.04 at its lowest and $3.50 at its peak.
During the past year, Rein Therapeutics(RNTX) stock moved between $1.04 at its lowest and $3.50 at its peak.
People also own
Based on the portfolios of people who own RNTX. This list is generated using Robinhood data, and it’s not a recommendation.